•
Dec 31, 2021

Immix Biopharma Q4 2021 Earnings Report

EPS
-$6.16
Previous year: -$0.101
+5994.8%
Cash and Equivalents
$17.6M
Free Cash Flow
-$1.11M
Total Assets
$18.2M

Immix Biopharma

Immix Biopharma